FDA
-
-
-
-
-
-
-
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
-
-
-
-
-
-
-
Orchard Therapeutics Announces Presentation of Additional Positive Data from Proof-of-concept Study of OTL-203 in MPS-IH at ESGCT 2023
-
-
-
-
-
-
-
Orchard Therapeutics Plc (ORTX) Completes Submission of BLA for OTL-200 in MLD to U.S. FDA
-
-
-
-
-
-
-
Weekly biotech pulse: X4 Pharma data on deck, AbbVie set for FDA review
-
-
-
-
-
-
-
Orchard Therapeutics Announces Strategic Financing Totalling up to $188 Million
-
-
-
-
-
-
-
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
-
-
-
-
-
-
-
Orchard Therapeutics Announces First Neurocognitive Data from OTL-201 Study in MPS-IIIA Accepted for Oral Presentation at ASH 2022
-
251,770 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All